Chronic Kidney Disease and Hypertension

ISBN-13: 9781493947041 / Angielski / Miękka / 2016 / 257 str.

Matthew R. Weir; Edgar V. Lerma

Opis

The treatment of hypertension has become the most important intervention in the management of all forms of chronic kidney disease. Chronic Kidney Disease and Hypertension is a current, concise, and practical guide to the identification, treatment and management of hypertension in patients with chronic kidney disease. In depth chapters discuss many relevant clinical questions and the future of treatment through medications and or novel new devices.Written by expert authors, Chronic Kidney Disease and Hypertension provides an up-to-date perspective on management and treatment and how it may re-shape practice approaches tomorrow.

Recenzje

"This book reviews the etiology, pathogenesis, and treatment guidelines for patients with chronic kidney disease and hypertension. The goal is to provide a guide for all healthcare professionals, both clinical and research, in the management of hypertension, especially in the expanding population of patients with chronic kidney disease and end-stage renal disease. ... This is an excellent resource for all practitioners, educators, and students on the intricacies of hypertension and how it affects all patients." (Temitope Shodunke, Doody's Book Reviews, October, 2015)

Spis treści

Ch. 1: Changes in Guideline Trends and Applications in Practice: JNC 2013 and the future
Hala Yamout
George L. Bakris

Ch. 2: Central BP monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD
Debbie L. Cohen
Yonghong Huan
Raymond R. Townsend

Ch. 3: Resistant hypertension in patients with chronic kidney disease
Mohsin Wali
Sudhir R. Naik
C. Venkata S. Ram

Ch. 4: Neurogenic Factors In Hypertension Associated With Chronic Kidney Disease
Vito M. Campese

Ch. 5: Novel Molecules
Valeria Lourdes Vukelic
Marcelo Orias

Ch. 6: Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?
Domenic A. Sica

Ch. 7: Renal Sympathetic Denervation
Markus P. Schlaich

Ch. 8: Novel baroreceptor activation therapy
Peter W. de Leeuw
Abraham A. Kroon

Ch. 9: Blood Pressure Vaccines
Sorot Phisitkul
Joel Topf

Ch. 10: Masked Hypertension: Does it Lead to CVD or CKD?
F. Wilford Germino

Ch. 11: White Coat Hypertension- Do We Really Understand It Now?
Luis M. Ruilope

Ch. 12: Uric Acid And Hypertension - Is There Really A Link?
Anuradha Wadhwa
Shinichiro Inaba
Richard J. Johnson

Ch. 13: Preeclampsia: Angiogenic factors, blood pressure, and the kidney
Frank T. Spradley
Eric Matthew George
Ana Carolina Palei
Junie Paula Warrington
Joey P. Granger

Ch.14: Inflammation and Hypertension
Paolo Pauletto
Marcello Rattazzi

Ch. 15: Genome-Wide Association Studies (Gwas) Of Blood Pressure In Different Populations
Srividya Kidambi
Theodore A. Kotchen

Ch. 16: Endocrine Hypertension and Chronic Kidney Disease
Christian A. Koch
Christina Pamporaki
Vitaly Kantorovich
 

Ch. 17: Hypertension in Children with Chronic Kidney Disease
Douglas L. Blowey
Bradley A. Warady

Ch. 18: Obesity/OSA/Metabolic syndrome in pts with CKD and hypertension-the missing link
Mugurel Apetrii
Luminita VoroneanuAdrian C. Covic

O autorze

Matthew R. Weir, MD
Professor and Director, Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

Edgar V. Lerma, MD
Clinical Professor of Medicine, Section of Nephrology, Christ Medical Center, University of Illinois at Chicago/Advocate, Oak Lawn, IL, USA